Besides ocular symptoms, a large number of OPA1 variants have been associated with additional clinical complications including auditory neuropathy, myopathy and ataxia, which define a new type of disease, termed ADOA-plus syndrome [105]. The gene discussed is OPA1; the disease is autosomal dominant optic atrophy.